Skip to main content
SpringerLink
Log in

Differential Expression of Three Matrix Metalloproteinases, MMP-19, MMP-26, and MMP-28, in Normal and Inflamed Intestine and Colon Cancer

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Several matrix metalloproteinases (MMPs) have been implicated in intestinal inflammation, mucosal wound healing, and cancer progression. The purpose of this study was to examine the cellular location and putative function of MMP-19, MMP-26 (matrilysin-2), and MMP-28 (epilysin), in normal, inflammatory, and malignant conditions of the intestine. Peroperative tissue specimens from patients with ulcerative colitis (UC) (n = 16) and archival tissue samples of ischemic colitis (n = 9), Crohn's disease (n = 7), UC (n = 8), colon cancer (n = 20), and healthy intestine (n = 5) were examined using immunohistochemical analyses with polyclonal antibodies. Unlike many classical MMPs, MMP-19, MMP-26, and MMP-28 were all expressed in normal intestine. In inflammatory bowel disease (IBD), MMP-19 was expressed in nonmigrating enterocytes and shedding epithelium. MMP-26 was detected in migrating enterocytes, unlike MMP–28. In colon carcinomas, MMP-19 and MMP-28 expression was downregulated in tumor epithelium. Staining for MMP-26 revealed a meshwork-like pattern between cancer islets, which was absent from most dedifferentiated areas. Our results suggest that MMP-19 is involved in epithelial proliferation and MMP-26 in enterocyte migration, while MMP-28 expression is not associated with inflammatory and destructive changes seen in IBD. In contrast to many previously characterized MMPs, MMP-19 and MMP-28 are downregulated during malignant transformation of the colon and may play a prominent role in tissue homeostasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nagase H, Woessner J: Matrix metalloproteinases. J Biol Chem 274:21491-21494, 1999

    Google Scholar 

  2. Uria J, López-Otin C: Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency and activity. Cancer Res 60:4745-4751, 2000

    Google Scholar 

  3. Lohi JL, Wilson CL, Roby JD, Parks WC: Epilysin: A novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 276:10134-10144, 2001

    Google Scholar 

  4. Ahokas K, Lohi J, Lohi H, Elomaa O, Karjalainen-Lindsber ML, Kere J, Saarialho-Kere U: Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer. Gene 301:31-41, 2002

    Google Scholar 

  5. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA, Lim MS: The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes Relat Metab Disord 3:9-15, 1996

    Google Scholar 

  6. Gomez D, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological function. Eur J Cell Biol 74:111-122, 1997

    Google Scholar 

  7. Schonbeck U, Mach F, Libby PJ: Generation of biologically active IL-1beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161:3340-3346, 1998

    Google Scholar 

  8. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM: Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 105:143-150, 2000

    Google Scholar 

  9. Bresnihan B: Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 26:717-719, 1999

    Google Scholar 

  10. Ishiguro N, Ito T, Ito H, Iwata H, Jugessur H, Ionescu M, Poole AR: Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arth Rheum 42:129-136, 1999

    Google Scholar 

  11. Westermarck J, Kähäri VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 8:781-792, 1999

    Google Scholar 

  12. Schonbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P: Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 81:448-454, 1997

    Google Scholar 

  13. Saarialho-Kere UK: Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 90290:47-54, 1998

    Google Scholar 

  14. Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U: Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13, macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 4:1005-1014, 1998

    Google Scholar 

  15. Salmela MT, MacDonald TT, Black D, Irvine B, Zhuma T, Saarialho-Kere U, Pender SL: Upregulation of matrix metalloproteinases during T-cell mediated injury in the gut—Analysis by gene array and in situ hybridization. Gut 51:540-547, 2002

    Google Scholar 

  16. Cossins J, Dudgeon TJ, Catlin G, Gearing JA, Clements JM: Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun 228:494-498, 1996

    Google Scholar 

  17. Pendas A, Knäuper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G, Lopez-Otin C: Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location and tissue distribution. J Biol Chem 272:4281-4286, 1997

    Google Scholar 

  18. Sedlacek R, Mauch S, Kolb B, Schatzlein C, Eibel H, Peter HH, Schmitt J, Krawinkel U: Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Immunobiology 198:137-143, 1998

    Google Scholar 

  19. Kolb C, Mauch S, Krawinkel U, Sedlacek R: Matrix metalloproteinase-19 in capillary andothelial cells: expression in acutely, but not in chronically, inflamed synovium. Exp Cell Res 250:122-130, 1999

    Google Scholar 

  20. Djonov V, Högger K, Sedlacek R, Laissue J, Draeger A: MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol 195:147-155, 2001

    Google Scholar 

  21. Mauch S, Kolb C, Kolb B, Sadowski T, Sedlacek R: Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion dependent manner and associates with the cell surface. J Immunol 3:1244-1251, 2002

    Google Scholar 

  22. Stracke J, Hutton M, Stewart M, Pendas AM, Smith B, Lopez-Otin C, Murphy G, Knauper V: Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J Biol Chem 275:14809-14816, 2000

    Google Scholar 

  23. Stracke J, Fosang JA, Last K, Mercuri FA, Pendas AM, Llano E, Perris R, DiCesare Pe, Murphy G, Knauper V: Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett 478:52-65, 2000

    Google Scholar 

  24. de Coignac A, Elson G, Delneste Y, Magistrelli G, Jeannin P, Aubry JP, Berthier O, Schmitt D, Bonnefoy JY, Gauchat JF: Cloning of MMP-26: a novel matrilysin-like proteinase. Eur J Biochem 267:3323-3329, 2000

    Google Scholar 

  25. Park H, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QX: Identification and characterization of human endometase (MMP-26) from endometrial tumor. J Biol Chem 275:20540-20544, 2000

    Google Scholar 

  26. Marchenko G, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI, Strongin AY: Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J 356:705-718, 2001

    Google Scholar 

  27. Zhang J, Cao Y-J, Zhao Y-G, Sang Q-X, Duan E-K: Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Rep 7:659-666, 2002

    Google Scholar 

  28. Isaka K, Nishi H, Nakai H, Nakada T, Feng Li Y, Ebihara Y, Takayama: Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer 97:79-89, 2003

    Google Scholar 

  29. Zhao Y-G, Xiao A-Z, Newcomer RG, Park HI, Kang T, Chung LWK, Swanson MG, Zhau HE, Kurhanewicz J, Sang QA: Activation of pro-gelatinase B by endometase-/Matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem 278:15056-15064, 2003

    Google Scholar 

  30. Illman SA, Keski-Oja J, Lohi J: Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene 275:185-194, 2001

    Google Scholar 

  31. Marchenko GN, Strongin AY: MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene 265:87-93, 2001

    Google Scholar 

  32. Saarialho-Kere U, Kerkelä E, Jahkola T, Suomela S, Keski-Oja J, Lohi J: Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J Invest Dermatol 119:14-21, 2002

    Google Scholar 

  33. Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg ML: Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 2:19-526, 1996

    Google Scholar 

  34. Salmela MT, Pender SLF, Reunala T, MacDonald T, Saarialho-Kere U: Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. Gut 48:96-502, 2001

    Google Scholar 

  35. Pender SL, Salmela MT, Monteleone G, Schnapp D, McKenzie C, Spencer J, Fong S, Saarialho-Kere U, MacDonald TT: Ligation of alpha4β1 integrin on human intestinal mucosal mesenchymal cells selectively up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. Am J Pathol 6:955-1962, 2000

    Google Scholar 

  36. Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R, Kahari VM, Saarialho-Kere U: MMP-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 103:709-716, 2003

    Google Scholar 

  37. Li Q, Wang H, Zhao Y, Lin H, Sang QA, Zhu C: Identification and specific expression of matrix metalloproteinase-26 in rhesus monkey endometrium during early pregnancy. Mol Hum Reprod 10:34-940, 2002

    Google Scholar 

  38. Vihinen P, Kahari VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2:57-166, 2002

    Google Scholar 

  39. Suomela S, Kariniemi A-L, Impola U, Karvonen SL, Snellman E, Uurasmaa T, Peltonen J, Saarialho-Kere U: MMP-19 is expressed by keratinocytes in psoriasis. Acta Dermatovenereol 83:108-114, 2003

    Google Scholar 

  40. Hieta N, Impola U, Lopez-Otin C, Saarialho-Kere U, Kähäri VM: Matrix metalloproteinase-19 expression in wound healing and in dermal fibroblasts. J Invest Dermatol 121:997-1004, 2003

    Google Scholar 

  41. Yu WH, Woessner JF Jr: Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275:183-4191, 2000

    Google Scholar 

  42. von Bredow DC, Nagle RB, Bowden GT, Cress AE: Cleavage of beta 4 integrin by matrilysin. Exp Cell Res 236:41-345, 1997

    Google Scholar 

  43. Illman S, Keski-Oja J, Parks WC, Lohi J: Mouse Epilysin (MMP-28) is alternatively spliced and processed by a furin-like pro-protein convertase. Biochem J 375:191-197, 2003

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Helsinki, Helsinki, Finland

    V.-O. Bister & M. T. Salmela

  2. Department of Pathology, University of Helsinki, Helsinki, Finland

    M.-L. Karjalainen-Lindsberg & J. Lohi

  3. Departmento Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006, Oviedo, Spain

    J. Uria & C. Lopez-Otin

  4. Department of Surgery, University of Helsinki, Helsinki, Finland

    P. Puolakkainen

  5. Clinical Research Center, Karolinska Institute and Huddinge University Hospital, Stockholm, Sweden

    U. Saarialho-Kere

Authors
  1. V.-O. Bister
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. T. Salmela
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M.-L. Karjalainen-Lindsberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Uria
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Lohi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Puolakkainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Lopez-Otin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. U. Saarialho-Kere
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bister, VO., Salmela, M.T., Karjalainen-Lindsberg, ML. et al. Differential Expression of Three Matrix Metalloproteinases, MMP-19, MMP-26, and MMP-28, in Normal and Inflamed Intestine and Colon Cancer. Dig Dis Sci 49, 653–661 (2004). https://doi.org/10.1023/B:DDAS.0000026314.12474.17

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000026314.12474.17

Search

Navigation